Insider Stock Trading History of Landgraf John C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Landgraf John C since year 2005. The trader's CIK number is 1298968. At the time of this reporting, Landgraf John C is the Executive Vice President of Abbott Laboratories . (stock ticker symbol ABT). See this page for all insider trading activities at Abbott Laboratories .


Stock purchases, sales, and option exercises reported by insider Landgraf John C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-06-03 ABT Abbott Laboratories Option Ex 18,203 31.79 578,691
2014-03-03 ABT Abbott Laboratories Sale 17,293 39.39 681,136
2014-02-18 ABT Abbott Laboratories Option Ex 1,583 35.03 55,452
2014-02-18 ABT Abbott Laboratories Sale 1,583 39.10 61,900
2014-02-07 ABT Abbott Laboratories Option Ex 21,972 32.16 706,531
2014-02-07 ABT Abbott Laboratories Sale 21,972 36.96 811,975
2013-02-19 ABT Abbott Laboratories Sale 3,066 34.78 106,638
2012-09-07 ABT Abbott Laboratories Option Ex 38,565 53.16 2,049,922
2012-08-31 ABT Abbott Laboratories Option Ex 140,258 52.08 7,303,935
2012-08-31 ABT Abbott Laboratories Sale 130,944 65.50 8,576,832
2012-03-19 ABT Abbott Laboratories Option Ex 30,000 44.16 1,324,800
2012-03-19 ABT Abbott Laboratories Sale 30,000 60.00 1,800,000
2012-03-12 ABT Abbott Laboratories Sale 30,000 58.16 1,744,800
2012-03-12 ABT Abbott Laboratories Option Ex 30,000 44.16 1,324,800
2012-02-29 ABT Abbott Laboratories Sale 16,887 56.72 957,847
2011-12-02 ABT Abbott Laboratories Option Ex 53,201 53.62 2,852,903
2011-12-02 ABT Abbott Laboratories Sale 53,201 54.63 2,906,530
2011-02-28 ABT Abbott Laboratories Sale 13,992 48.03 672,049
2010-10-29 ABT Abbott Laboratories Option Ex 10,640 49.19 523,424
2010-02-26 ABT Abbott Laboratories Sale 13,583 54.42 739,241
2010-02-16 ABT Abbott Laboratories Sale 1,700 53.91 91,650
2010-02-17 ABT Abbott Laboratories Sale 10,240 54.88 561,971
2009-09-24 ABT Abbott Laboratories Sale 35,000 47.00 1,645,000
2009-02-17 ABT Abbott Laboratories Sale 884 54.44 48,126
2009-02-04 ABT Abbott Laboratories Option Ex 2,200 45.45 99,985
2009-02-03 ABT Abbott Laboratories Sale 13,683 56.00 766,248
2009-02-03 ABT Abbott Laboratories Option Ex 22,252 42.94 955,589
2008-08-06 ABT Abbott Laboratories Option Ex 26,056 46.42 1,209,519
2008-08-06 ABT Abbott Laboratories Option Ex 26,056 46.42 1,209,519
2008-07-09 ABT Abbott Laboratories Option Ex 24,651 45.45 1,120,338
2008-03-03 ABT Abbott Laboratories Option Ex 2,353 42.50 99,995
2008-02-08 ABT Abbott Laboratories Option Ex 1,879 53.19 99,944
2008-02-08 ABT Abbott Laboratories Sale 21,879 56.86 1,244,127
2008-02-11 ABT Abbott Laboratories Option Ex 8,421 56.30 474,102
2008-02-11 ABT Abbott Laboratories Sale 8,421 56.33 474,354
2007-11-30 ABT Abbott Laboratories Option Ex 15,710 45.45 713,988
2007-08-09 ABT Abbott Laboratories Option Ex 9,738 43.73 425,842
2007-08-08 ABT Abbott Laboratories Option Ex 29,016 42.66 1,237,909
2007-08-07 ABT Abbott Laboratories Option Ex 13,806 41.72 576,055
2007-08-03 ABT Abbott Laboratories Option Ex 8,333 39.26 327,153
2007-03-01 ABT Abbott Laboratories Option Ex 3,529 37.42 132,062
2007-03-01 ABT Abbott Laboratories Sale 20,529 54.27 1,114,170
2007-01-31 ABT Abbott Laboratories Option Ex 67,278 38.40 2,583,340
2007-01-31 ABT Abbott Laboratories Sale 7,033 53.04 373,030
2006-04-03 ABT Abbott Laboratories Sale 10,000 42.41 424,099
2006-02-21 ABT Abbott Laboratories Sale 310 43.86 13,596
2006-02-14 ABT Abbott Laboratories Option Ex 18,231 33.23 605,834
2006-02-15 ABT Abbott Laboratories Option Ex 11,383 34.77 395,809
2006-02-15 ABT Abbott Laboratories Sale 637 43.49 27,703
2006-02-07 ABT Abbott Laboratories Option Ex 24,807 33.23 824,361

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Landgraf John C (Executive Vice President of Abbott Laboratories at the time of this reporting) see the Securities and Exchange Commission (SEC) website.